Found 4 matching trials
Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy PHASE2 The purpose of this study is to determine whether TAC-101 as a second line ...
Show More Location
I.R.C.C.S. San Matteo University Hospital, Golgi
Learn More & Join Trial
TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) PHASE1 RATIONALE: TAC-101 may stop the growth of cancer by stopping blood flow to ...
Show More Location
MD Anderson Cancer Center at University of Texas
Learn More & Join Trial
A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma PHASE2 The purpose of this study is to evaluate the efficacy and safety of TAC-101...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma PHASE2 The purpose of this study is to determine whether TAC-101 combined with Tra...
Show More Location
Aichi Cancer Center Hospital
Learn More & Join Trial